INVITE: Real World Implications from ATS Data Releases and Recent Pulmonary Launches with Dr. Haider Ali; Guggenheim Grand Rounds

Research evidence excerpt

INVITE: Real World Implications from ATS Data Releases and Recent Pulmonary Launches with Dr. Haider Ali; Guggenheim Grand Rounds

Biotechnology May 22, 2026

Vamil Divan, M.D.

vamil.divan@guggenheimpartners.com INVITE: Real World Implications from ATS Data

212 823 6543 Releases and Recent Pulmonary Launches with Dr. Seamus Fernandez

seamus.fernandez@guggenheimpartners.com Haider Ali; Guggenheim Grand Rounds

617 859 4637

Daniel Krizay, Ph.D. Please join us for a discussion with Dr. Haider Ali, M.D., Pulmonologist at Northside daniel.krizay@guggenheimpartners.com

212 823 6561 Hospital in Atlanta, GA, on Friday, May 29th at 10:00AM ET. In this call we will discuss

key data from the American Thoracic Society Conference (e.g. Tyvaso [UTHR] TETON-1

Arseniy Shabashvili data in IPF, Arikayce [INSM] ENCORE data in MAC), the current landscape and future

arseniy.shabashvili@guggenheimpartners.com outlook for multiple lung diseases including IPF, bronchiectasis, MAC lung disease, 212 699 1971

and COPD, and Dr. Ali’s personal experience to date with multiple respiratory products

Edouard Mullarky, Ph.D. including Brinsupri (INSM), Arikayce (INSM), Ohtuvayre (MRK), Jascayd (Boehringer

edouard.mullarky@guggenheimpartners.com Ingelheim; Private), and more.

212 518 9579

Potentially Impacted Companies: INSM, MRK, VICO-SS, UTHR, Boehringer Ingelheim

(Private)

Ticker Price Rating

INSM 109.53 Buy Date and Time

MRK 115.88 Buy Friday, May 29, 2026 | 10:00 AM – 11:00 AM ET

VICO-SS 10.90 Buy

Conference Call Format

Virtual Group Meeting w/ Email Q&A

Registration Information

Please register HEREor contact your Guggenheim Sales Representative.

Participating KOL

Dr. M. Haider Ali is a Physician for Pulmonary and Critical Care of Atlanta at Northside

Hospital (08/2019-present).